Cerner (NASDAQ:CERN) had its price objective lowered by research analysts at Robert W. Baird from $80.00 to $75.00 in a report issued on Wednesday, February 7th. The firm currently has an “outperform” rating on the stock. Robert W. Baird’s target price would indicate a potential upside of 20.02% from the stock’s current price.
Other analysts have also issued research reports about the stock. Cantor Fitzgerald restated a “buy” rating and issued a $77.00 target price on shares of Cerner in a research report on Tuesday, October 10th. Zacks Investment Research lowered shares of Cerner from a “buy” rating to a “hold” rating in a research note on Thursday, January 4th. SunTrust Banks restated a “buy” rating and set a $79.00 target price on shares of Cerner in a research note on Thursday, October 19th. Evercore ISI started coverage on shares of Cerner in a research note on Thursday, January 18th. They set an “in-line” rating and a $77.00 target price on the stock. Finally, BidaskClub lowered shares of Cerner from a “hold” rating to a “sell” rating in a research note on Wednesday, January 24th. One research analyst has rated the stock with a sell rating, twelve have assigned a hold rating and eight have assigned a buy rating to the company. Cerner currently has a consensus rating of “Hold” and a consensus price target of $67.05.
Cerner (NASDAQ:CERN) remained flat at $$62.49 during trading on Wednesday. 2,692,700 shares of the stock were exchanged, compared to its average volume of 2,544,275. The stock has a market capitalization of $20,784.01, a P/E ratio of 24.22, a PEG ratio of 1.87 and a beta of 0.90. The company has a debt-to-equity ratio of 0.11, a quick ratio of 2.99 and a current ratio of 3.01. Cerner has a 52 week low of $54.01 and a 52 week high of $73.86.
Cerner (NASDAQ:CERN) last released its quarterly earnings results on Tuesday, February 6th. The company reported $0.58 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.61 by ($0.03). Cerner had a net margin of 16.86% and a return on equity of 16.82%. The company had revenue of $1.31 billion during the quarter, compared to the consensus estimate of $1.33 billion. During the same period in the prior year, the company earned $0.61 earnings per share. The firm’s revenue was up 4.5% compared to the same quarter last year. research analysts predict that Cerner will post 2.42 earnings per share for the current fiscal year.
In other news, CEO Clifford W. Illig sold 140,000 shares of the stock in a transaction that occurred on Thursday, November 16th. The stock was sold at an average price of $65.52, for a total value of $9,172,800.00. Following the completion of the sale, the chief executive officer now directly owns 1,229,719 shares of the company’s stock, valued at $80,571,188.88. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director William D. Zollars sold 4,100 shares of the stock in a transaction that occurred on Thursday, February 8th. The shares were sold at an average price of $62.16, for a total value of $254,856.00. The disclosure for this sale can be found here. Insiders sold 788,100 shares of company stock valued at $52,181,816 over the last ninety days. 13.11% of the stock is currently owned by corporate insiders.
Several hedge funds have recently bought and sold shares of CERN. Icon Wealth Partners LLC acquired a new stake in shares of Cerner in the fourth quarter valued at approximately $107,000. Advisory Services Network LLC lifted its stake in shares of Cerner by 4.4% in the 2nd quarter. Advisory Services Network LLC now owns 1,648 shares of the company’s stock valued at $110,000 after purchasing an additional 70 shares in the last quarter. Fuller & Thaler Asset Management Inc. acquired a new position in shares of Cerner in the 3rd quarter valued at about $121,000. Cerebellum GP LLC acquired a new position in shares of Cerner in the 4th quarter valued at about $127,000. Finally, Steward Partners Investment Advisory LLC acquired a new position in shares of Cerner in the 3rd quarter valued at about $128,000. 81.58% of the stock is owned by institutional investors and hedge funds.
TRADEMARK VIOLATION WARNING: “Cerner (NASDAQ:CERN) Price Target Cut to $75.00” was originally posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this report on another site, it was illegally stolen and republished in violation of United States & international trademark & copyright law. The legal version of this report can be read at https://www.dispatchtribunal.com/2018/02/14/cerner-cern-pt-lowered-to-75-00.html.
Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations of all sizes. The Company’s segments include Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States.
Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.